Peter John Fellner
Direktor/Vorstandsmitglied bei Ligand UK Development Ltd.
Ursprung des Netzwerks ersten Grades von Peter John Fellner
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
50
| Public Company | Pharmaceuticals: Major | 50 |
35
| Subsidiary | Medical Specialties | 35 |
| Public Company | Biotechnology | 31 | |
| Subsidiary | Pharmaceuticals: Major | 28 | |
22
| Subsidiary | Pharmaceuticals: Major | 22 |
20
| Public Company | Pharmaceuticals: Major | 20 |
| Subsidiary | Pharmaceuticals: Major | 19 | |
13
| Subsidiary | Biotechnology | 13 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.
11
| Extinct | Biotechnology | 11 |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom.
10
| Extinct | Pharmaceuticals: Major | 10 |
| Public Company | Aerospace & Defense | 10 | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.
10
| Subsidiary | Biotechnology | 10 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Ligand UK Development Ltd.
 Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a company that manufactures pharmaceutical products. The company is based in Winnersh, UK.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter John Fellner
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member General Counsel Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel President | |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Chief Executive Officer Director/Board Member Private Equity Investor Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Comptroller/Controller/Auditor Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RECORDATI | Pharmaceuticals: Major | Director/Board Member Chairman | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SURGICAL INNOVATIONS GROUP PLC | Medical Specialties | Chairman Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| BIONOMICS LIMITED | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Director/Board Member Corporate Officer/Principal General Counsel | |
| University of London | College/University | Graduate Degree Director/Board Member Doctorate Degree | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Davis | College/University | Director/Board Member Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Sheffield | College/University | Undergraduate Degree Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Consultant / Advisor Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member President Director/Board Member | |
| MOLECULAR PARTNERS AG | Biotechnology | Chairman Chairman | |
| PFENEX INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Founded in 1995, Ligand UK Group Ltd. is a subsidiary of Ligand Pharmaceuticals, Inc. and functions as an investment holding company. The company is based in Cambridge, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Public Communications Contact | |
Stevenage Bioscience Catalyst
 Stevenage Bioscience Catalyst BiotechnologyHealth Technology Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Chief Operating Officer Director/Board Member | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman Chairman | |
Medical House Products Ltd.
 Medical House Products Ltd. Medical SpecialtiesHealth Technology Part of Recipharm AB, Medical House Products Ltd. is a British company that manufactures medical and surgical equipment. The company is based in Hemel Hempstead, UK. | Medical Specialties | Director/Board Member Director/Board Member | |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member | |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Chief Operating Officer Chairman | |
Vernalis (R&D) Ltd.
 Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigtes Königreich | 26 |
| Vereinigte Staaten | 13 |
| Deutschland | 5 |
| Schweden | 4 |
| Irland | 2 |
Sektoral
| Health Technology | 29 |
| Commercial Services | 10 |
| Consumer Services | 7 |
| Finance | 4 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 644 |
| Corporate Officer/Principal | 231 |
| Independent Dir/Board Member | 182 |
| Chairman | 174 |
| Chief Executive Officer | 107 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Frank Armstrong | 41 |
| Timothy Haines | 36 |
| Bo Jesper Hansen | 34 |
| Flemming Ørnskov | 34 |
| Deepa Pakianathan | 32 |
| Michael Wyzga | 31 |
| James Manuso | 29 |
| Thomas Fulton Wilson McKillop | 28 |
| Anders Olof Adolf Ekblom | 27 |
| William Burns | 27 |
| Ismail Kola | 26 |
| Guido Magni | 23 |
| Stephen Crummett | 22 |
| Chris Brinsmead | 22 |
- Börse
- Insiders
- Peter John Fellner
- Unternehmensverbindungen
